This website is intended for people who are prescribed Novo Nordisk pens for growth hormone disorders only. Side effects information can be found in the footer of this page.
These are not real patients and are for illustrative purposes only.
Why PenCycle®?
Your pre-filled Novo Nordisk pens can now be recycled!
Through PenCycle®, every pen returned to us will be reclaimed and repurposed, avoiding tonnes of waste.
PenCycle® —
You return it
We recycle it!
But, did you know that in 2023, in Novo Nordisk in the UK alone
almost
25 million
used injection pens went into landfill?
That amounts to
420 tonnes
of plastic waste. This is not sustainable.
These are not real patients and are for illustrative purposes only.
By finding new
ways to reuse
our pens, we can
help to end the unsustainable
use of Earth’s
natural
resources
PenCycle® is a bespoke process that lets us recycle our pre-filled pens after use.
But, we can’t do this without help — everyone involved in prescribing, dispensing or using pens can help PenCycle® to achieve its aims. It’s a joint effort that may only take a few minutes but will have an impact that lasts for years.
And, importantly, PenCycle® will not only mean reduced waste, it will also help the NHS achieve its critical environmental targets.
These are not real patients and are for illustrative purposes only.
At Novo Nordisk, we're committed to environmental change. We have ambitious targets as part of our “Circular for Zero” initiative, including:
Using 100% renewable energy across our global production (which we have already achieved)
Re-designing both our existing and future products to reduce our waste
Working together with our supply partners to make our processes more environmentally friendly
Through PenCycle®, we want to make an even bigger difference by recycling empty, pre-filled Novo Nordisk pens.
Reporting of
side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.
Side effects should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored for training purposes. By reporting side effects, you can help provide more information on the safety of this medicine.